Suppr超能文献

人类动脉粥样硬化的动物模型:当前进展。

Animal models of human atherosclerosis: current progress.

机构信息

Institute for Atherosclerosis Research, Skolkovo Innovative Center, Moscow, Russia.

Core Facility Centre, Institute of Gene Biology, Russian Academy of Sciences, Moscow, Russia.

出版信息

Braz J Med Biol Res. 2020;53(6):e9557. doi: 10.1590/1414-431x20209557. Epub 2020 May 18.

Abstract

Atherosclerosis retains the leading position among the causes of global morbidity and mortality worldwide, especially in the industrialized countries. Despite the continuing efforts to investigate disease pathogenesis and find the potential points of effective therapeutic intervention, our understanding of atherosclerosis mechanisms remains limited. This is partly due to the multifactorial nature of the disease pathogenesis, when several factors so different as altered lipid metabolism, increased oxidative stress, and chronic inflammation act together leading to the formation and progression of atherosclerotic plaques. Adequate animal models are currently indispensable for studying these processes and searching for novel therapies. Animal models based on rodents, such as mice and rats, and rabbits represent important tools for studying atherosclerosis. Currently, genetically modified animals allow for previously unknown possibilities in modelling the disease and its most relevant aspects. In this review, we describe the recent progress made in creating such models and discuss the most important findings obtained with them to date.

摘要

动脉粥样硬化在全球范围内的发病率和死亡率原因中仍占据首要地位,尤其在工业化国家中更是如此。尽管我们一直在努力研究疾病发病机制并寻找潜在的有效治疗干预点,但我们对动脉粥样硬化机制的理解仍然有限。这部分是由于疾病发病机制的多因素性质,当几种截然不同的因素,如脂质代谢改变、氧化应激增加和慢性炎症共同作用,导致动脉粥样硬化斑块的形成和进展。目前,充分的动物模型对于研究这些过程和寻找新的治疗方法是必不可少的。基于啮齿动物(如小鼠和大鼠)和兔子的动物模型是研究动脉粥样硬化的重要工具。目前,基因修饰动物为模拟疾病及其最重要方面提供了以前未知的可能性。在这篇综述中,我们描述了在创建这些模型方面取得的最新进展,并讨论了迄今为止从这些模型中获得的最重要发现。

相似文献

1
Animal models of human atherosclerosis: current progress.
Braz J Med Biol Res. 2020;53(6):e9557. doi: 10.1590/1414-431x20209557. Epub 2020 May 18.
5
Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine.
Pharmacol Ther. 2015 Feb;146:104-19. doi: 10.1016/j.pharmthera.2014.09.009. Epub 2014 Sep 30.
6
Large animal models of atherosclerosis--new tools for persistent problems in cardiovascular medicine.
J Pathol. 2016 Jan;238(2):257-66. doi: 10.1002/path.4646. Epub 2015 Oct 27.
7
Imaging of atherosclerosis: magnetic resonance imaging.
Eur Heart J. 2011 Jul;32(14):1709-19b. doi: 10.1093/eurheartj/ehr068. Epub 2011 Apr 19.
8
Lymphatic vessels: an emerging actor in atherosclerotic plaque development.
Eur J Clin Invest. 2015 Jan;45(1):100-8. doi: 10.1111/eci.12372.
9
Animal models to evaluate anti-atherosclerotic drugs.
Fundam Clin Pharmacol. 2015 Aug;29(4):329-40. doi: 10.1111/fcp.12130. Epub 2015 Jun 29.
10
An update on the tools for creating transgenic animal models of human diseases - focus on atherosclerosis.
Braz J Med Biol Res. 2019;52(5):e8108. doi: 10.1590/1414-431X20198108. Epub 2019 Apr 25.

引用本文的文献

1
[Advances in Animal Modeling in the Study of Bone-Vascular Axis Comorbidities].
Sichuan Da Xue Xue Bao Yi Xue Ban. 2025 Mar 20;56(2):355-363. doi: 10.12182/20250360504.
2
Chitosan-Based Nanoparticles Targeted Delivery System: In Treatment Approach for Dyslipidemia.
Int J Nanomedicine. 2025 May 24;20:6611-6636. doi: 10.2147/IJN.S517492. eCollection 2025.
4
The Cholesterol Paradox in Long-Livers from a Sardinia Longevity Hot Spot (Blue Zone).
Nutrients. 2025 Feb 21;17(5):765. doi: 10.3390/nu17050765.
5
Innovative mRNA Vaccine Approaches in Targeting Atherosclerosis: A New Era in Cardiovascular Therapy.
Cureus. 2024 Nov 21;16(11):e74141. doi: 10.7759/cureus.74141. eCollection 2024 Nov.
6
Non-rodent Models of Atherosclerosis: Repurposing of Existing Drugs and Search for Novel Treatment Strategies.
Curr Cardiol Rev. 2025;21(1):e1573403X316529. doi: 10.2174/011573403X316529240919103119.
8
A Novel Artificial Coronary Plaque to Model Coronary Heart Disease.
Biomimetics (Basel). 2024 Mar 26;9(4):197. doi: 10.3390/biomimetics9040197.
10
The Potential Effects of Dietary Antioxidants in Obesity: A Comprehensive Review of the Literature.
Healthcare (Basel). 2024 Feb 6;12(4):416. doi: 10.3390/healthcare12040416.

本文引用的文献

1
Inflammation, infection and atherosclerosis.
Trends Cardiovasc Med. 2019 Nov;29(8):468-472. doi: 10.1016/j.tcm.2019.01.004. Epub 2019 Jan 28.
3
Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week.
J Am Coll Cardiol. 2018 Oct 23;72(17):2071-2081. doi: 10.1016/j.jacc.2018.08.1043.
4
The role of non-resolving inflammation in atherosclerosis.
J Clin Invest. 2018 Jul 2;128(7):2713-2723. doi: 10.1172/JCI97950.
5
6
Critical roles of inflammation in atherosclerosis.
J Cardiol. 2019 Jan;73(1):22-27. doi: 10.1016/j.jjcc.2018.05.010. Epub 2018 Jun 12.
7
Roles of PAD4 and NETosis in Experimental Atherosclerosis and Arterial Injury: Implications for Superficial Erosion.
Circ Res. 2018 Jun 22;123(1):33-42. doi: 10.1161/CIRCRESAHA.117.312494. Epub 2018 Mar 23.
8
Regression of atherosclerosis: lessons learned from genetically modified mouse models.
Curr Opin Lipidol. 2018 Apr;29(2):87-94. doi: 10.1097/MOL.0000000000000493.
10
Principles and Applications of Rabbit Models for Atherosclerosis Research.
J Atheroscler Thromb. 2018 Mar 1;25(3):213-220. doi: 10.5551/jat.RV17018. Epub 2017 Oct 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验